← Back to Clinical Trials
Recruiting NCT07374107

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Trial Parameters

Condition IBM
Sponsor Myositis International Health & Research Collaborative Alliance Foundation
Study Type OBSERVATIONAL
Phase N/A
Enrollment 700
Sex ALL
Min Age 7 Years
Max Age N/A
Start Date 2025-06-25
Completion 2030-12
Interventions
No intervention - qualitative and mixed methods investigations

Brief Summary

Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly online) methods of open-ended questions, community forums and survey to identify the most pressing research concerns as identified by patients. Findings will be analyzed to create a patient-voiced set of research priorities that can guide the direction of research and help inform funding decisions across myositis diseases. Potential participants can express interest via https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/

Eligibility Criteria

Inclusion Criteria: * Ability to provide informed consent * Have a clinician diagnosis of an idiopathic inflammatory myopathy or be a care partner or parent of a person living with an idiopathic inflammatory myopathy. * Participants who may have signed up through the MIHRA Patient Contact Registry https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/ Exclusion Criteria: * Under the age of 7 years old * Do not have a diagnosis of an inflammatory myopathy

Related Trials